Inamed pipeline balloons
This article was originally published in The Gray Sheet
Executive Summary
Cohesive Silicone Gel Matrix breast implant application will be submitted to FDA in mid-2004, firm says. Inamed also is in talks with the agency concerning a regulatory pathway and late 2004 launch of a "ribbed" version of its Lap-band laparoscopic adjustable gastric band for morbid obesity. The company will decide by year-end whether to commence trials of an Intragastric Balloon, approved in Europe for temporary weight loss in obese patients...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.